125 related articles for article (PubMed ID: 7775138)
1. Phase II study of edatrexate in advanced head and neck cancer. A Southwest Oncology Group study.
Kuebler JP; Benedetti J; Schuller DE; Ensley J; Grunberg SM; Muirhead MJ; Richert-Boe KE; Marshall ME
Invest New Drugs; 1994; 12(4):341-4. PubMed ID: 7775138
[TBL] [Abstract][Full Text] [Related]
2. Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study.
Schornagel JH; Verweij J; de Mulder PH; Cognetti F; Vermorken JB; Cappelaere P; Armand JP; Wildiers J; de Graeff A; Clavel M
J Clin Oncol; 1995 Jul; 13(7):1649-55. PubMed ID: 7602354
[TBL] [Abstract][Full Text] [Related]
3. A phase II trial of edatrexate in previously treated squamous cell cervical cancer: a Gynecologic Oncology Group study.
Broun ER; Iseminger KA; Rose PG; Lentz SL; Malfetano JH; Lincoln S; Mannel R
Am J Clin Oncol; 1997 Feb; 20(1):78-80. PubMed ID: 9020294
[TBL] [Abstract][Full Text] [Related]
4. A phase II trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck. The EORTC Head and Neck Cancer Cooperative Group.
Schornagel JH; Verweij J; de Mulder PH; Cognetti F; Vermorken JB; Cappelaere P; Armand JP; Wildiers J; Clavel M; Kirkpatrick A
Ann Oncol; 1992 Mar; 3(3):223-6. PubMed ID: 1586620
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of carboplatin and edatrexate (10-EdAM) with leucovorin rescue for patients with recurrent squamous cell carcinoma of the head and neck.
Huber MH; Dimery IW; Benner SE; Lippman SM; Shirinian M; Esparaz B; Frenning D; Guillory-Perez C; Hong WK
Invest New Drugs; 1994; 12(4):327-31. PubMed ID: 7775135
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of 10-EdAM in patients with squamous cell carcinoma of the head and neck, previously untreated with chemotherapy.
Green MD; Sherman P; Zalcberg J
Invest New Drugs; 1992 Apr; 10(1):31-4. PubMed ID: 1607252
[TBL] [Abstract][Full Text] [Related]
7. A phase II trial of edatrexate in previously treated ovarian cancer. A Gynecologic Oncology Group study.
Broun ER; Iseminger KA; Bookman M
Am J Clin Oncol; 1995 Apr; 18(2):164-6. PubMed ID: 7900709
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of topotecan in patients with recurrent for metastatic squamous cell carcinoma of the head and neck. A phase II Southwest Oncology Group study.
Smith RE; Lew D; Rodriguez GI; Taylor SA; Schuller D; Ensley JF
Invest New Drugs; 1996; 14(4):403-7. PubMed ID: 9157077
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of edatrexate in relapsed or refractory germ cell tumors: a Southwest Oncology Group study (SWOG 9124).
Meyers FJ; Lew D; Lara PN; Williamson S; Marshall E; Balcerzak SP; Rivkin SE; Samlowski W; Crawford ED
Invest New Drugs; 1998-1999; 16(4):347-51. PubMed ID: 10426670
[TBL] [Abstract][Full Text] [Related]
10. Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin.
Laurie SA; Pfister DG; Kris MG; Tong WP; Chronowski G; Pisters KM; Heelan RT; Sirotnak FM
Clin Cancer Res; 2001 Mar; 7(3):501-9. PubMed ID: 11297240
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of edatrexate in chemotherapy-naive patients with metastatic breast cancer.
Schornagel JH; van der Vegt S; Verweij J; de Graeff A; Dullemond-Westland A; van Deijk WA; ten Bokkel Huinink WW
Ann Oncol; 1992 Jul; 3(7):549-52. PubMed ID: 1498076
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma.
Pazdur R; Moore DF; Bready B; Giannone L; Maldonado A; Lin YG; Fueger RH; Winn RJ; Levin B
Ann Oncol; 1994 Sep; 5(7):646-8. PubMed ID: 7527654
[TBL] [Abstract][Full Text] [Related]
13. Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma. Sequential phase II trials by the cancer and leukemia group B.
Kindler HL; Belani CP; Herndon JE; Vogelzang NJ; Suzuki Y; Green MR
Cancer; 1999 Nov; 86(10):1985-91. PubMed ID: 10570422
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer.
D'Andrea G; Fennelly D; Norton L; Baselga J; Gilewski T; Hudis C; Moynahan ME; Raptis G; Sklarin N; Surbone A; Theodoulou M; Templeton MA; Yao TJ; Seidman AD
Clin Cancer Res; 1999 Feb; 5(2):275-9. PubMed ID: 10037175
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer.
Ho AL; Lipson BL; Sherman EJ; Xiao H; Fury MG; Apollo A; Seetharamu N; Sima CS; Haque S; Lyo JK; Sales R; Cox L; Pfister DG
Invest New Drugs; 2014 Jun; 32(3):549-54. PubMed ID: 24566705
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of edatrexate in patients with metastatic colorectal cancer.
Clamon GH; Riggs CE; Dreicer R; Hohl RJ
Invest New Drugs; 1996; 13(4):359-61. PubMed ID: 8824357
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.
Moore DF; Pazdur R; Abbruzzese JL; Ajani JA; Dubovsky DW; Wade JL; Belt RJ; Mangold C; Bready B; Winn RJ
Ann Oncol; 1994 Mar; 5(3):286-7. PubMed ID: 8186177
[TBL] [Abstract][Full Text] [Related]
18. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
[TBL] [Abstract][Full Text] [Related]
19. Edatrexate in patients with soft tissue sarcoma. Activity in malignant fibrous histiocytoma.
Casper ES; Christman KL; Schwartz GK; Johnson B; Brennan MF; Bertino JR
Cancer; 1993 Aug; 72(3):766-70. PubMed ID: 8392904
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of edatrexate in patients with advanced renal cell carcinoma. An Eastern Cooperative Oncology Group study.
Dreicer R; Propert KJ; Kuzel T; Kirkwood JM; O'Dwyer PJ; Loehrer PJ
Am J Clin Oncol; 1997 Jun; 20(3):251-3. PubMed ID: 9167747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
